Sanofi Q2 sales up 6% despite earnings fall prediction
This article was originally published in Scrip
French drugmaker Sanofi expects earnings to fall this year, hit by the loss of patents on drugs. However, it generated sales of €8.87 billion, up 6% in the second quarter, boosted by a 6 percentage point exchange rate effect. In addition, business net income at €1.94 million showed a slower than expected decline at 9.6% for the quarter.